Open access
Open access
Powered by Google Translator Translator

Internal Medicine

M-A | Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease

24 Mar, 2023 | 13:02h | UTC

Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis – European Respiratory Review

 


Role of sleep in peripheral artery disease risk: Insights from cohort and mendelian randomization studies

24 Mar, 2023 | 13:01h | UTC

Sleep duration, daytime napping, and risk of peripheral artery disease: multinational cohort and Mendelian randomization studies – European Heart Journal Open

News Release: Short night-time sleep linked with nearly doubled risk of clogged leg arteries – European Society of Cardiology

 


Study reveals high rates of nonadherence to antimicrobial prophylaxis guidelines, often due to unnecessary vancomycin use

23 Mar, 2023 | 13:13h | UTC

Summary: The study evaluated adherence to surgical antimicrobial prophylaxis guidelines in 825 US hospitals for elective surgeries from 2019-2020. The study found that 41% of surgical prophylaxis regimens were nonadherent to the American Society of Health-System Pharmacists guidelines.

Unnecessary vancomycin use was the most common reason for nonadherence to surgical antimicrobial prophylaxis guidelines, accounting for 77% of nonadherent regimens and occurring in 31% of all surgeries. It’s noteworthy that when vancomycin was used, it was often unnecessarily combined with cefazolin, and patients who received this combination had a 19% higher risk of acute kidney injury compared to those who received cefazolin alone.

The authors suggest that quality-improvement efforts aimed at reducing unnecessary vancomycin use and potential guideline revisions may offer impactful strategies for improving the risk-benefit profile of antimicrobial prophylaxis.

Article: Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries Across 825 US Hospitals, 2019–2020 – Clinical Infectious Diseases

 


Study reveals overuse of surveillance colonoscopy in older adults with limited life expectancy

23 Mar, 2023 | 13:11h | UTC

Summary: This study investigated the association between estimated life expectancy, surveillance colonoscopy findings, and follow-up recommendations among older adults. The study utilized data from the New Hampshire Colonoscopy Registry and included adults over 65 who underwent colonoscopy for surveillance after prior polyps.

Life expectancy was estimated using a validated prediction model and categorized into three groups: less than 5 years, 5 to less than 10 years, and 10 or more years.

Out of the 9,831 adults included in the study, 8% had advanced polyps or CRC. Among the 5,281 patients with available recommendations, 86.9% were advised to return for a future colonoscopy. Surprisingly, 58.1% of older adults with less than 5 years of life expectancy were also recommended to return for future surveillance colonoscopy.

The study concluded that many older adults with limited life expectancy are still recommended for future surveillance colonoscopy. This data could help refine decision-making about pursuing or stopping surveillance colonoscopy in older adults with a history of polyps.

Article: Association of Life Expectancy With Surveillance Colonoscopy Findings and Follow-up Recommendations in Older Adults – JAMA Internal Medicine (link to abstract – $ for full-text)

JAMA Patient Page: What Should I Know About Stopping Routine Cancer Screening?

 

Commentary on Twitter

 


Survey | Perspectives of patients about immediate access to test results through an online patient portal

23 Mar, 2023 | 13:02h | UTC

Summary: This study aimed to assess patient and caregiver attitudes and preferences related to receiving immediately released test results through an online patient portal.

In a survey of 8,139 respondents across 4 US academic medical centers, 95,7% of patients preferred to receive immediately released test results through an online patient portal, even if their healthcare practitioner had not yet reviewed the result. However, 7.5% of respondents reported that reviewing results before being contacted by a healthcare practitioner increased worry. This worry was more common among respondents who received abnormal results (16.5%) compared to those whose results were normal (5%).

The authors concluded that balancing patients’ expectations of immediate access to their information with the need to manage increased worry and healthcare practitioner burden is important as healthcare systems navigate this new era of health information transparency.

Article: Perspectives of Patients About Immediate Access to Test Results Through an Online Patient Portal – JAMA Network Open

News Release: Patients prefer immediate access to medical test results online, even if it’s bad news – UT Southwestern Medical Center

 

Commentary from one of the authors on Twitter

 


Cohort Study | Retinal artery occlusion linked to a 7-fold higher mortality rate from CV and cerebrovascular diseases

23 Mar, 2023 | 13:04h | UTC

Summary: This nationwide cohort study analyzed the incidence of retinal artery occlusion (RAO) in Korea from 2002 to 2018, along with related mortality and causes of death. The incidence of RAO was found to be 7.38 per 100,000 person-years, with a higher incidence of noncentral RAO compared to central RAO.

Patients with RAO had a mortality rate about 7 times higher than the general population, primarily due to cardiovascular or cerebrovascular diseases. The findings emphasize the need to address the risk of cardiovascular or cerebrovascular disease in patients newly diagnosed with RAO.

Article: Incidence of Retinal Artery Occlusion and Related Mortality in Korea, 2005 to 2018 – JAMA Network Open

Invited Commentary: Long-term Management Considerations for Retinal Artery Occlusion and Cardiovascular and Cerebrovascular Mortality – JAMA Network Open

 


RCT | Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause

23 Mar, 2023 | 13:01h | UTC

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study – The Lancet (link to abstract – $ for full-text)

Related: Efficacy and Safety of Fezolinetant in Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT – The Journal of Clinical Endocrinology & Metabolism

 

Commentary on Twitter (thread – click for more)

 


Guideline | Diagnosis and treatment of myocarditis

23 Mar, 2023 | 12:55h | UTC

JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis – Circulation Journal (see PDF)

Related: Brazilian Society of Cardiology Guideline on Myocarditis – 2022 – Arquivos Brasileiros de Cardiologia

 


Guideline | Diagnosis and treatment of vasospastic angina and coronary microvascular dysfunction

23 Mar, 2023 | 12:53h | UTC

JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction – Circulation Journal (see PDF)

 


An evidence-based guide to the efficacy and safety of isometric resistance training in hypertension

23 Mar, 2023 | 12:42h | UTC

An evidence-based guide to the efficacy and safety of isometric resistance training in hypertension and clinical implications – Clinical Hypertension

 


M-A | Effects of dairy intake on markers of cardio-metabolic health in adults

23 Mar, 2023 | 12:35h | UTC

Effects of dairy intake on markers of cardio-metabolic health in adults – a systematic review with network meta-analysis – Advances in Nutrition

 

Commentary on Twitter

 


Best practice in the use of peripheral venous catheters: a scoping review and expert consensus

23 Mar, 2023 | 12:37h | UTC

Best practice in the use of peripheral venous catheters: A scoping review and expert consensus – Infection Prevention in Practice

 


M-A | eHealth-based psychosocial interventions for adults with insomnia

23 Mar, 2023 | 12:31h | UTC

eHealth-Based Psychosocial Interventions for Adults With Insomnia: Systematic Review and Meta-analysis of Randomized Controlled Trials – Journal of Medical Internet Research

 


AHA Scientific Statement | Supervised exercise training for chronic heart failure with preserved ejection fraction

22 Mar, 2023 | 13:46h | UTC

Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology – Circulation

News Release: Exercise therapy is safe, may improve quality of life for many people with heart failure – American Heart Association

Key Points: Supervised Exercise Training for Chronic HFpEF – American College of Cardiology

 


RCT | Hydrocortisone reduces mortality in severe community-acquired pneumonia

22 Mar, 2023 | 13:44h | UTC

Summary: Practice-changing! In a phase 3, multicenter, double-blind, randomized controlled trial involving 800 patients with severe community-acquired pneumonia admitted to the ICU, hydrocortisone treatment was found to reduce the risk of death by day 28 compared to a placebo group. The hydrocortisone group had a 6.2% death rate, while the placebo group had an 11.9% death rate.

Hydrocortisone also led to fewer endotracheal intubations among patients not on mechanical ventilation at baseline and reduced the need for vasopressor therapy in patients not receiving it at baseline. There was no significant difference in hospital-acquired infections or gastrointestinal bleeding between the two groups, but patients in the hydrocortisone group required higher daily doses of insulin during the first week of treatment.

Article: Hydrocortisone in Severe Community-Acquired Pneumonia – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Steroid drug reduces death rate in severe pneumonia, study shows – STAT

 

Commentary on Twitter

 


Review | Diagnosis and treatment of chronic lymphocytic leukemia

22 Mar, 2023 | 13:39h | UTC

Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review – JAMA (free for a limited period)

Audio clinical review: Diagnosis and Management of Chronic Lymphocytic Leukemia – JAMA

 


Elevated pre- & postoperative BNP tied to complications in hypertensive & diabetic patients undergoing surgery

22 Mar, 2023 | 13:28h | UTC

Summary: This study aimed to assess if preoperative and postoperative serum B-type natriuretic peptide levels (BNP) could predict postoperative complications in hypertensive and diabetic patients after non-cardiac surgery. The study involved 260 adult participants and measured BNP levels before and after surgery. The primary outcome was the change in BNP levels and the development of postoperative complications within 30 days of surgery.

Results showed that patients who developed postoperative complications had significantly higher serum BNP levels both before and after surgery. The preoperative BNP levels (baseline BNP) in patients with complications were 152.02 pg/mL ± 106.56 compared to 44.90 pg/mL ± 44.22 in patients without complications. Similarly, postoperative BNP levels in patients with complications were 313.99 pg/mL ± 121.29, while in patients without complications, they were 83.95 pg/mL ± 70.19.

Although the study does not provide specific cutoff values, higher BNP levels both preoperatively and postoperatively are associated with an increased risk of complications in hypertensive and diabetic patients undergoing non-cardiac surgery. Further multicenter prospective studies with a larger population are needed to confirm the role of BNP in predicting surgical prognosis.

Article: Serum B-type natriuretic peptide levels (BNP) can be used as a predictor of complications in patients undergoing non-cardiac surgery: a prospective observational study – Open Heart

Related:

The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all‐cause mortality in patients who undergo noncardiac surgery – Cochrane Library

Preoperative N-Terminal Pro–B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery: A Cohort Study – Annals of Internal Medicine

The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis – Journal of the American College of Cardiology

 


Phase 2b RCT | New oral PCSK9 inhibitor reduces LDL cholesterol by 40% to 60%

22 Mar, 2023 | 13:20h | UTC

Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial – Journal of the American College of Cardiology

Commentary: Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study – TCTMD

 


Exploratory analysis | Hypoglycemia incidence is lower with linagliptin vs. glimepiride in patients with early type 2 DM

22 Mar, 2023 | 13:15h | UTC

Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial – Diabetes, Obesity and Metabolism

Original Study: Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial – JAMA

 


RCT | Electronic nudges resulted in modest increase in influenza vaccination uptake in older adults

22 Mar, 2023 | 13:10h | UTC

Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial – The Lancet (link to abstract – $ for full-text)

News Release: Electronic Messages Improved Influenza Vaccination Rates in Nationwide Danish Study – Brigham and Women’s Hospital

Commentary: Linking Flu Vaccine to Cardiovascular Benefit Could Increase Uptake in Older Adults – HCP Live

 


Position Paper | Patient sleep during hospitalization

21 Mar, 2023 | 13:47h | UTC

Society of Anesthesia and Sleep Medicine Position Paper on Patient Sleep During Hospitalization – Anesthesia & Anesthesia (free for a limited period)

 


Comparative study highlights women’s lower susceptibility to sudden cardiac arrest during sports

21 Mar, 2023 | 13:44h | UTC

Summary: This study assessed the incidence, characteristics, and outcomes of sports-related sudden cardiac arrest (Sr-SCA) in women. Data from three European registries were analyzed, identifying 34,826 SCA cases between 2006 and 2017, with 760 cases (2.2%) being Sr-SCA, including 54 in women.

The average annual incidence of Sr-SCA in women was 0.19 per million, over 10 times lower than in men (2.63 per million). When extrapolated to the European population, this translates to 98 cases per year in women and 1,350 cases in men.

Characteristics, bystander response, time to defibrillation, and survival rates did not significantly differ between women and men. The findings highlight the considerably lower risk of Sr-SCA in women compared to men and should be considered when designing preparticipation screening strategies in the future.

Article: Incidence of Cardiac Arrest During Sports Among Women in the European Union – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentary: Incidence of Cardiac Arrest During Sports Among Women – American College of Cardiology

 

Commentary on Twitter

 


The paradox of endurance training: higher coronary plaque prevalence found in lifelong athletes

21 Mar, 2023 | 13:42h | UTC

Summary: The Master@Heart study aimed to investigate the relationship between lifelong endurance exercise and coronary atherosclerosis measured by computed tomography coronary angiography (CTCA) in a cohort of 191 lifelong master endurance athletes, 191 late-onset athletes, and 176 healthy non-athletes. All participants were male with a low cardiovascular risk profile.

The study found that lifelong endurance sport participation was not associated with a more favorable coronary plaque composition compared to maintaining a healthy lifestyle. In fact, lifelong endurance athletes exhibited a higher prevalence of coronary plaques, including more non-calcified plaques in proximal segments, than fit and healthy individuals with a similarly low cardiovascular risk profile.

Further research is needed to understand how these findings on CTCA might translate into clinical events in endurance athletes.

Article: Lifelong endurance exercise and its relation with coronary atherosclerosis – European Heart Journal

Commentaries:

Lifelong Endurance Exercise and Coronary Atherosclerosis – American College of Cardiology

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis – TCTMD

 


RCT | Time-restricted eating not more effective than daily calorie restriction for managing nonalcoholic fatty liver disease

21 Mar, 2023 | 13:38h | UTC

Summary: The TREATY-FLD randomized clinical trial investigated the effects of time-restricted eating (TRE) versus daily calorie restriction (DCR) on intrahepatic triglyceride (IHTG) content and metabolic risk factors in patients with obesity and nonalcoholic fatty liver disease (NAFLD).

Participants were randomly assigned to either TRE (eating only between 8:00 am and 4:00 pm) or DCR (habitual meal timing) and instructed to maintain a diet of 1500 to 1800 kcal/d for men and 1200 to 1500 kcal/d for women for 12 months.

The study found that the IHTG content was reduced by 6.9% in the TRE group and 7.9% in the DCR group after 12 months, a difference that was not statistically significant. Furthermore, TRE did not produce additional benefits for reducing body weight, liver stiffness, or metabolic risk factors compared with DCR.

The study supports that the main focus of a diet for managing NAFLD is caloric restriction, which can be achieved both with a TRE strategy or without a TRE strategy with similar results.

Article: Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial – JAMA Network Open

Commentary: Time-Restricted Eating Not More Beneficial Than Calorie Restriction For Patients With NAFLD, Obesity – HCP Live

 

Commentary on Twitter

 


SR | Topical antibiotics modestly improve resolution of acute bacterial conjunctivitis

21 Mar, 2023 | 13:33h | UTC

Summary: The Cochrane Review evaluated the benefits and potential side effects of antibiotic therapy in treating acute bacterial conjunctivitis. The authors included 21 randomized controlled trials, with a total of 8,805 participants. The trials evaluated the effectiveness of topical antibiotic treatments in the form of drops or ointments, and were heterogeneous in terms of eligibility criteria, antibiotic drug class, duration of treatment, and outcomes assessed.

The review found that antibiotics likely improved clinical cure by 26% compared with placebo, with no evidence of serious systemic side effects reported in either the antibiotic or placebo group. Fluoroquinolones were found to have fewer ocular side effects compared to non-fluoroquinolones.

Overall, the review suggests that the use of topical antibiotics may be considered to achieve better clinical and microbiologic efficacy than placebo in treating acute bacterial conjunctivitis.

Article: Antibiotics versus placebo for acute bacterial conjunctivitis – Cochrane Library

Summary: What are the benefits and harms of antibiotics for acute bacterial conjunctivitis? – Cochrane Library

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.